Richardson Syndrome Variant of Progressive Supranuclear Palsy: A Case Report

Progressive supranuclear palsy (PSP) is a chronic neurodegenerative disease, an atypical parkinsonism with four-repeat tau neuropathology. PSP-Richardson syndrome (PSP-RS) is the most prevalent clinical variant of PSP, originally described as the prototypical form of the disease. It is defined by vertical supranuclear gaze palsy (most prominently affecting downward gaze), early postural instability with frequent falls, and a subcortical-frontal pattern of cognitive impairment. The diagnosis of PSP is mainly based on clinical data and is only definitively confirmed at autopsy. Neuroimaging plays an important role in early diagnosis. Our report describes the case of a 72-year-old female patient who had experienced subtle symptoms for approximately two years prior to presentation. Initially, she exhibited slow and monotonous speech, mild decline in fine motor skills, intermittent episodes of impaired concentration, and mild forgetfulness. At presentation to the outpatient clinic, she reported falls, imbalance, bradykinesia, cognitive decline, limitation of vertical gaze, and diplopia. The patient's systemic examination was normal. Neurological examination showed vertical gaze palsy, postural instability, bradykinesia, and a shuffling gait. Bilateral upper extremity associative movements were slow. The Mini-Mental State Examination Score was 19. Axial T2-weighted magnetic resonance imaging (MRI) showed midbrain atrophy, as well as the hummingbird sign and morning glory sign, characteristic of PSP. Axial T1 MRI showed cerebral atrophy and dilatation of the bilateral lateral and third ventricles. Initially, levodopa/benserazide was started at a dose of 500 mg/day and increased up to 1,000 mg/day. Amantadine at a dose of 200 mg/day and levodopa/carbidopa sustained release at a dose of 200/50 mg/day were added to the treatment regimen, but no effective clinical response was observed. Balance and walking exercises were provided by the physical therapy and rehabilitation department. This case highlights the subtle prodromal features and progressive course of PSP, emphasizing the importance of early recognition. It also contributes to the literature by illustrating the clinical progression and therapeutic challenges in managing PSP, underscoring the value of a multidisciplinary approach to optimize patient outcomes.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-12-02
DOI
https://doi.org/10.7759/cureus.98307
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Richardson Syndrome Variant of Progressive Supranuclear Palsy: A Case Report

İbrahim KORUCU, Tuba Karakoyun Alpay
Cureus
Parkinson's Disease Mechanisms and Treatments
article

Richardson Syndrome Variant of Progressive Supranuclear Palsy: A Case Report

İbrahim KORUCU, Tuba Karakoyun Alpay
article en

Abstract

Progressive supranuclear palsy (PSP) is a chronic neurodegenerative disease, an atypical parkinsonism with four-repeat tau neuropathology. PSP-Richardson syndrome (PSP-RS) is the most prevalent clinical variant of PSP, originally described as the prototypical form of the disease. It is defined by vertical supranuclear gaze palsy (most prominently affecting downward gaze), early postural instability with frequent falls, and a subcortical-frontal pattern of cognitive impairment. The diagnosis of PSP is mainly based on clinical data and is only definitively confirmed at autopsy. Neuroimaging plays an important role in early diagnosis. Our report describes the case of a 72-year-old female patient who had experienced subtle symptoms for approximately two years prior to presentation. Initially, she exhibited slow and monotonous speech, mild decline in fine motor skills, intermittent episodes of impaired concentration, and mild forgetfulness. At presentation to the outpatient clinic, she reported falls, imbalance, bradykinesia, cognitive decline, limitation of vertical gaze, and diplopia. The patient's systemic examination was normal. Neurological examination showed vertical gaze palsy, postural instability, bradykinesia, and a shuffling gait. Bilateral upper extremity associative movements were slow. The Mini-Mental State Examination Score was 19. Axial T2-weighted magnetic resonance imaging (MRI) showed midbrain atrophy, as well as the hummingbird sign and morning glory sign, characteristic of PSP. Axial T1 MRI showed cerebral atrophy and dilatation of the bilateral lateral and third ventricles. Initially, levodopa/benserazide was started at a dose of 500 mg/day and increased up to 1,000 mg/day. Amantadine at a dose of 200 mg/day and levodopa/carbidopa sustained release at a dose of 200/50 mg/day were added to the treatment regimen, but no effective clinical response was observed. Balance and walking exercises were provided by the physical therapy and rehabilitation department. This case highlights the subtle prodromal features and progressive course of PSP, emphasizing the importance of early recognition. It also contributes to the literature by illustrating the clinical progression and therapeutic challenges in managing PSP, underscoring the value of a multidisciplinary approach to optimize patient outcomes.

CureusVol. 17(12)
State Hospital (GB), Setas (Turkey) (TR)
Openalex Percentile: Top 48%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.